XML 70 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of share-based compensation expenses

Year ended December 31, 

    

2020

2021

    

2022

(in thousands)

Cost of revenues

$

87

682

 

481

Research and development

4,467

17,662

 

15,345

General and administrative

368

2,367

 

2,193

Sales and marketing

603

3,163

 

2,612

Total compensation

$

5,525

23,874

 

20,631

Income tax benefit

$

1,176

4,896

 

4,201

Schedule of RSUs activity under the long-term incentive plan

    

Number of

    

Weighted

Underlying

Average Grant

Shares for RSUs

Date Fair Value

Balance at January 1, 2020

 

18,493

$

7.34

Granted

1,402,714

3.44

Vested

(1,392,355)

3.47

Forfeited

(5,963)

6.57

Balance at December 31, 2020

 

22,889

 

3.88

Granted

 

2,604,545

 

10.39

Vested

 

(2,237,499)

 

10.37

Forfeited

 

(3,415)

 

4.38

Balance at December 31, 2021

 

386,520

 

10.17

Granted

3,987,509

5.09

Vested

(3,563,177)

5.25

Forfeited

(18,643)

10.15

Balance at December 31, 2022

792,209

6.71

Schedule of allocation of compensation expenses and related tax effects from the RSUs granted to employees under the long-term incentive plan

Year ended December 31, 

    

2020

2021

    

2022

(in thousands)

Cost of revenues

$

70

676

 

472

Research and development

3,924

17,592

 

15,097

General and administrative

319

2,343

 

1,934

Sales and marketing

520

3,149

 

2,497

Total compensation

$

4,833

23,760

 

20,000

Income tax benefit

$

1,044

4,896

 

4,201

Schedule of valuation assumptions

    

2019 plan

 

Valuation assumptions:

 

  

Expected dividend yield

 

3.5

%

Expected volatility

 

51.96%-57.79

%

Expected term (years)

 

1-1.5

Risk-free interest rate

 

1.69%-1.75

%

Schedule of stock option activity

Weighted

Weighted

average

average

remaining

Number

exercise

contractual

    

of Units

    

price

    

term

Balance at January 1, 2020

 

2,226,690

$

2.27

 

1.5

Granted

163,500

3.05

0.88

Exercised

(1,574,869)

2.32

Forfeited

(236,853)

2.30

Balance at December 31, 2020

578,468

2.36

0.54

Exercised

(524,387)

2.37

Expired

(54,081)

2.27

Balance at December 31, 2021

-

-

-

Exercisable at December 31, 2021

 

-

-

-

(b)Employee stock options
(i)On March 19, 2021, board of directors of CM Visual Technology Corp. approved a plan to grant stock options, the 2021 plan, to certain employees. This plan authorizes grants to purchase up to 3,000,000 shares of CM Visual Technology Corp.’ authorized but unissued ordinary shares. The exercise price was NT$10 (US$0.36).
CM Visual Technology Corp  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2021 plan

Valuation assumptions:

Expected dividend yield

 

0%

Expected volatility

 

43.82%

Expected term (years)

 

3.125

Risk-free interest rate

 

0.223%

Schedule of stock option activity

    

    

    

    

    

Weighted

 

 

Weighted

 

average

 

 

average

 

remaining

Number

 

exercise

 

contractual

of shares

 

price

 

term

Balance at January 1, 2021

 

-

$

-

Granted

 

2,791,000

 

0.36

 

  

Exercised

 

-

 

-

 

  

Forfeited

 

(120,000)

 

0.36

 

  

Balance at December 31, 2021

 

2,671,000

 

0.36

 

3.5

Forfeited

(380,000)

0.36

Balance at December 31, 2022

2,291,000

0.36

2.5

Exercisable at December 31, 2022

 

-

 

-

 

-

Liqxtal Technology Inc  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2021 plan

Valuation assumptions:

Expected dividend yield

 

0%

Expected volatility

 

30.06%

Expected term (years)

 

1.25

Risk-free interest rate

 

0.107%

Schedule of stock option activity

    

    

    

    

    

Weighted

 

Weighted

 

average

 

average

 

remaining

 

Number

 

exercise

 

contractual

 

of shares

 

price

 

term

Balance at January 1, 2021

 

-

$

-

 

  

Granted

 

1,000,000

 

0.65

 

  

Exercised

 

-

 

-

 

  

Forfeited

 

(90,000)

 

0.65

 

  

Balance at December 31, 2021

 

910,000

 

0.65

 

1.0

Exercised

(840,000)

0.65

Forfeited

(70,000)

0.65

Balance at December 31, 2022

-

-

-

Exercisable at December 31, 2022

 

-

 

-

 

-

Emza  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2022 Option Plan

 

Valuation assumptions:

 

Expected dividend yield

 

0

%

Expected volatility

 

54.05

%

Expected term (years)

 

6.11

Risk-free interest rate

 

0.65

%

Schedule of stock option activity

    

    

    

Weighted

Weighted

average

average

remaining

Number

exercise

contractual

of shares

price

term

Balance at January 1, 2022

 

$

 

Granted

 

150,940

 

20.49

 

6.11

Exercised

 

 

 

Forfeited

 

(1,797)

 

20.49

 

Cancelled

 

(149,143)

 

20.49

 

Balance at December 31, 2022

 

 

 

Exercisable at December 31, 2022